This article is more than 1 month old.

Will antibody cocktail of Roche reduce demand for Tocilizumab: Delhi HC

Mini

The Delhi High Court has asked the Centre whether demand for COVID19 drug Tocilizumab, which is in short supply, would be reduced if drug major Roche provides its new antibody cocktail that has been approved for emergency use in India for coronavirus patients. The court also asked the Centre what quantities of the antibody cocktail would be required for the purpose of reducing demand for Tocilizumab.

Will antibody cocktail of Roche reduce demand for Tocilizumab: Delhi HC

Market Movers

CompanyPriceChange%Loss
Adani Ports718.70 -24.20
Wipro540.15 -16.40
Divis Labs4,224.60 -64.15
JSW Steel665.50 -9.75
Larsen1,479.25 -19.95
CompanyPriceChange%Loss
Kotak Mahindra1,736.80 -23.20
Larsen1,479.80 -19.35
Tata Steel1,099.80 -13.75
TCS3,262.10 -38.55
Axis Bank732.40 -7.20
CompanyPriceChange%Loss
Adani Ports718.70 -24.20 -3.26
Wipro540.15 -16.40 -2.95
Divis Labs4,224.60 -64.15 -1.50
JSW Steel665.50 -9.75 -1.44
Larsen1,479.25 -19.95 -1.33
CompanyPriceChange%Loss
Kotak Mahindra1,736.80 -23.20 -1.32
Larsen1,479.80 -19.35 -1.29
Tata Steel1,099.80 -13.75 -1.23
TCS3,262.10 -38.55 -1.17
Axis Bank732.40 -7.20 -0.97

Currency

CompanyPriceChng%Chng
Dollar-Rupee74.2700-0.0950-0.13
Euro-Rupee88.6270-0.1080-0.12
Pound-Rupee103.71900.05100.05
Rupee-100 Yen0.6701-0.0019-0.27